Ashish Verma
ashunephro.bsky.social
Ashish Verma
@ashunephro.bsky.social
Clinician Scientist at Boston University Chobanian & Avedisian School of Medicine.
Nephrologist at Boston Medical Center and BU Amyloidosis center
https://profiles.bu.edu/Ashish.Verma
Excited to share our comprehensive review “Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations” #CardiologyClinics @sophieclaudel.bsky.social @ahascience.bsky.social
@asnkidney.bsky.social
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
April 14, 2025 at 11:52 PM
Delighted to share our study published in @jaccjournals.bsky.social led by @sophieclaudel.bsky.social. We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression.
www.jacc.org/doi/10.1016/...
March 24, 2025 at 11:03 PM
Thrilled to share our state of art review led by extraordinary @sophieclaudel.bsky.social
“Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review"
www.ahajournals.org/eprint/SXXGK...

@ahascience.bsky.social
@ahajournals.bsky.social
@asnkidney.bsky.social
March 10, 2025 at 7:20 PM
Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality. academic.oup.com/eurjpc/artic... @sophieclaudel.bsky.social
January 6, 2025 at 2:22 AM